WDDMF News and Press, WeedMD From 06/21/18

Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, June 21st including WeedMD Inc. (TSXV:WMD) (OTC:WDDMF) and more... Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF) Shares of Auxly Cannabis Group Inc. rose 18.51% on higher tha...

Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Wednesday, June 20th including mCig Inc. (OTC:MCIG) and more... Cannabix Technologies Inc. (CSE:BLO) (OTC:BLOZF) Shares of Cannabix Technologies Inc. rose 12.82% on higher than average tr...

WeedMD ( OTCPK:WDDMF ) has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. More news on: WeedMD Inc, Healthcare stocks news, Read more ...

TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce it has entered into an agreement to become a medi...

Analysis Focus: WMGI Wright Medical Group N.V. ( WMGI ) stock prices climbed +4.46% to $25.78 on the news of its receipt of FDA premarket approval (‘PMA) for Augment. Augment, an injectable bone graft, is a combination product containing human platelet derived growth factor (rhPDGF...

TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Hiku Brands Company Ltd. (“ Hiku ”) (CSE:HIKU) and WeedMD Inc.  (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“ WeedMD ”) are pleased to announce that WeedMD has obtained an interim order from the Ontario Superior...

Revive Therapeutics ( OTCQB:RVVTF ) inks medical cannabis R&D supply and collaboration agreements with WeedMD ( OTCPK:WDDMF ) aimed at developing treatments for nonalcoholic steatohepatitis (NASH) and autoimmune hepatitis (AIH). More news on: Revive Therapeutics Ltd., WeedMD Inc, Hea...

TORONTO, June 13, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”) , a company focused on the research, development and commercialization of novel cannabinoid-based therapies, and WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE...

TORONTO, June 13, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“ WeedMD ”), a federally-licensed producer and distributor of medical cannabis, and Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”) , a company ...

The approval of cultivation license from Health Canada for the first four grow rooms within 220,000 sq. ft. puts WeedMD Inc. (OTCPK:WDDMF) in a strong position to capitalize on the boom in the cannabis industry. The potential cultivation from its phase 1 this summer will improve its pro...